Ibogaine is a psychedelic drug extracted from the roots of iboga, a shrub native to the rainforests of West Africa. While there have been no placebo- …
Why Psychedelic Drugs Market is Expected to See Overwhelming Growth in Coming Years newkerala.com#224235
PALM BEACH, Fla: The psychedelics drugs market has seen a surge in popularity over the pastdecade in the U.S. Psychedelics have been familiarly involved with healing and mental treatment practices with mind-altering substances since the dawn of time. However, research studies have generally stopped since psychedelic care was banned in the late 1960s. After being relegated to the margins of sincere scientific examination for about five decades, growing researchers and scientists are ...
Continue Reading →
Universal Ibogaine engages The Conscious Fund as a key advisor to help move the company forward
Universal Ibogaine Chairman Shane Nyquvest joined Steve Darling from Proactive with news the company has brought on as a strategic advisor. The fund will provide a range of advice related to such matters as strategic planning, fundraising, expansion opportunities, branding and messaging. Nyquvest telling Proactive why they decided to bring them on as advisors and what key milestones the company hopes to reach in 2021.
Researchers Develop Synthetic Ibogaine to Treat Depression, Addiction
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
Ibogaine is a psychoactive substance that triggers hallucinations; the substance is found in the Apocynaceae family of plants. Ibogaine has been used in spiritual ceremonies by the Bwiti tribe ...
New startup to focus on psychedelics' potential to treat addiction, depression
Ibogaine, a hallucinogenic substance derived from a west central African root, has shown promising results in treating addiction and depression.